Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advanced Pharmaceutical Bulletin is Scopus-indexed (Q1, CiteScore 7.7), WoS ESCI, DOAJ. Published by Tabriz University of Medical Sciences.
Checked against the index lists dated .
ISSN 2228-5881Verify ISSN ↗2251-7308Verify ISSN ↗
Publisher: Tabriz University of Medical Sciences
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 6 / 79 | 93rd | Q1 |
| Pharmaceutical Science | 40 / 191 | 79th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 7.7.
Advanced Pharmaceutical Bulletin is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 6 of 79) and Q1 in Pharmaceutical Science (rank 40 of 191), by CiteScore 2025.
Advanced Pharmaceutical Bulletin is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.795, quartile Q1, with an H-index of 70.
Advanced Pharmaceutical Bulletin is published by Tabriz University of Medical Sciences. Its print ISSN is 2228-5881 and its online ISSN is 2251-7308.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Advanced Pharmaceutical Bulletin has an h-index of 67 and a 2-year mean of 1.59 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #34 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Advanced Pharmaceutical Bulletin published 97 papers in 2025; its busiest recent year was 2020 with 162. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from Iran (57.7%), India (8.1%) and Egypt (3.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.